Collecting movement data from healthy children
Pediatric Normative Markerless Movement Analysis Data Collection Project
This study is collecting movement data from healthy children aged 3 to 25 to help understand how kids with leukemia move compared to their peers.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 40 (estimated) |
| Ages | 3 Years to 25 Years |
| Sex | All |
| Sponsor | MultiCare Health System Research Institute Academic / other |
| Locations | 1 site (Puyallup, Washington) |
| Trial ID | NCT06249880 on ClinicalTrials.gov |
What this trial studies
This project aims to gather baseline movement data from a normative population of children aged 3 to 25 years, matching the demographics of pediatric patients expected to be treated at the Mary Bridge Children's Research & Movement Lab. The study will recruit 20 male and 20 female typically developing individuals and will utilize non-invasive motion analysis and force plate data to assess their bipedal gait patterns. The collected data will serve as a reference for understanding movement in children with pediatric acute lymphoblastic leukemia (ALL).
Who should consider this trial
Good fit: Ideal candidates for this study are typically developing children aged 3 to 25 years who can walk independently.
Not a fit: Patients with neuromuscular disorders or developmental delays will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable normative data to improve the assessment and treatment of movement disorders in pediatric ALL patients.
How similar studies have performed: While similar studies have been conducted, this specific approach of collecting normative data for pediatric ALL patients is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age: 3-25 years of age (with 3 and 25 year olds considered for inclusion). * Ambulate independently and without the use of assistive devices or orthoses. * Willing and interested in participating. Exclusion Criteria: * Neuromuscular disorders such as cerebral palsy, muscular dystrophy, myotonic dystrophy, spinal muscular atrophy, peripheral neuropathy, or other generalized muscle and/or nerve issues. * Evidence of developmental delays, muscle weakness, decreased muscle tone, joint stiffness, muscle or bone deformity. * Currently using or has a history of using assistive technology devices, bracing/orthoses, manual or powered mobility equipment. * History of premature birth. * Currently or has a history of taking medication or pharmaceutical treatment related to musculoskeletal side-effects/scenario/diagnosis.
Where this trial is running
Puyallup, Washington
- Mary Bridge Children's Therapy Unit - Research & Movement Lab — Puyallup, Washington, United States (Recruiting)
Study contacts
- Principal investigator: Brenna Brandsma — Mary Bridge Chidlren's
- Study coordinator: Brenna Brandsma, PT, DPT, PCS
- Email: brenna.brandsma@multicare.org
- Phone: 253-697-5268
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.